Search
Add filters:
Use filters to refine the search results.
Item hits:
| Issue Date | Title | Author(s) |
|---|---|---|
| 2-Aug-2017 | Translating '–omics' results into precision medicine for hepatocellular carcinoma | Sia, Daniela; Llovet i Bayer, Josep Maria |
| 1-Mar-2017 | Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma | Tovar, Victoria; Cornella, Helena; Moeini, Agrin; Vidal, Samuel; Hoshida, Yujin; Sia, Daniela; Peix, Judit; Cabellos, Laia; Alsinet, Clara; Torrecilla, Sara; Martínez Quetglas, Iris; Lozano Salvatella, Juan José; Desbois-Mouthon, Christele; Sole, Manel; Domingo Domènech, Josep Maria; Villanueva, Augusto; Llovet i Bayer, Josep Maria |
| 2016 | Molecular liver cancer prevention in cirrhosis by organ transcriptome analysis and lysophosphatidic acid pathway inhibition | Nakagawa, Shigeki; Wei, Lan; Song, Won Min; Higashi, Takaaki; Ghoshal, Sarani; Kim, Rosa S.; Bian, C. Billie; Yamada, Suguru; Sun, Xiaochen; Venkatesh, Anu; Goossens, Nicolas; Bain, Gretchen; Lauwers, Gregory Y.; Koh, A. P.; El-Abtah, Mohamed; Ahmad, Noor B.; Hoshida, Hiroki; Erstad, Derek J.; Gunasekaran, Ganesh; Lee, Youngmin; Yu, Ming-Lung; Chuang, Wan-Long; Dai, Chia-Yen; Kobayashi, Masahiro; Kumada, Hiromitsu; Beppu, Toru; Baba, Hideo; Mahajan, Milind; Nair, Venugopalan D.; Lanuti, Michael; Villanueva, Augusto; Sangiovanni, Angelo; Iavarone, Massimo; Colombo, Massimo; Llovet i Bayer, Josep Maria; Subramanian, Aravind; Tager, Andrew M.; Friedman, Scott L.; Baumert, Thomas F.; Schwartz, Myron; Chung, Raymond T.; Tanabe, Kenneth K.; Zhang, Bin; Fuchs, Bryan C.; Hoshida, Yujin; Precision Liver Cancer Prevention Consortium |
| 1-Apr-2023 | Outcome of patients with hepatocellular carcinoma and liver dysfunction under Immunotherapy: a systematic review and meta-analysis | El Hajra, I.; Sanduzzi Zamparelli, M.; Sapena, V.; Muñoz Martínez, Sergio Gabriel; Mauro, E.; Llarch, N.; Iserte, G.; Forner, A.; Rios, J.; Bruix, J.; Reig, M. |
| 13-Nov-2020 | Effect of ramucirumab on ALBI grade in patients with advanced HCC: Results from REACH and REACH-2 | Kudo, Masatoshi; Galle, Peter R.; Brandi, Giovanni; Kang, Yoon Koo; Yen, Chia Jui; Finn, Richard S.; Llovet i Bayer, Josep Maria; Assenat, Eric; Merle, Philippe; Chan, Stephen L.; Palmer, Daniel H.; Ikeda, Masafumi; Yamashita, Tatsuya; Vogel, Arndt; Huang, Yi Hsiang; Abada, Paolo; Yoshikawa, Reigetsu; Shinozaki, Kenta; Wang, Chunxiao; Widau, Ryan C.; Zhu, Andrew X. |
| 14-Jun-2018 | Liver Cancer Disparities in New York City: A neighborhood wiew of risk and harm reduction factors | Kamath, Geetanjali R.; Taioli, Emanuela; Egorva, Natalia N.; Llovet i Bayer, Josep Maria; Perumalswami, Ponni V.; Weiss, Jeffrey J.; Schwartz, Myron; Ewala, Stanley; Bickell, Nina A. |
| 14-Nov-2020 | Pattern of progression in advanced hepatocellular carcinoma treated with ramucirumab | Reig, María; Galle, Peter R.; Kudo, Masatoshi; Finn, Richard; Llovet i Bayer, Josep Maria; Metti, Andrea L.; Schelman, William R.; Liang, Kun; Wang, Chunxiao; Widau, Ryan C.; Abada, Paolo; Zhu, Andrew X. |
| 30-Jul-2018 | Molecular therapies and precision medicine for hepatocellular carcinoma | Llovet i Bayer, Josep Maria; Montal, Robert; Sia, Daniela; Finn, Richard S. |
| 9-Jul-2019 | Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trials | Montal, Robert; Andreu Oller, Carmen; Bassaganyas, Laia; Esteban Fabró, Roger; Moran, Sebastian; Montironi, Carla; Moeini, Agrin; Pinyol, Roser; Peix, Judit; Cabellos, Laia; Villanueva, Augusto; Sia, Daniela; Mazzaferro, Vincenzo; Esteller, Manel; Llovet i Bayer, Josep Maria |
| 20-Mar-2014 | Reply to X. Qi et al ' Brivanib for Hepatocellular Carcinoma Trials: Selection Bias From Barcelona Clinic Liver Cancer Stage?' | Llovet i Bayer, Josep Maria; Johnson, Philip J. |
Discover
Subject